AIHC Capital Management
Latest statistics and disclosures from AIHC Capital Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002103725
Tip: Access up to 7 years of quarterly data
Positions held by AIHC Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIHC Capital Management
AIHC Capital Management holds 5 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 67.4 | $81M | 829k | 97.25 |
|
|
| Oric Pharmaceuticals (ORIC) | 26.0 | $31M | 2.5M | 12.67 |
|
|
| Novabridge Biosciences Sponsored Ads (NBP) | 4.7 | $5.6M | 2.3M | 2.46 |
|
|
| Cogent Biosciences (COGT) | 1.7 | $2.0M | 51k | 38.49 |
|
|
| Korro Bio (KRRO) | 0.3 | $343k | 30k | 11.32 |
|
Past Filings by AIHC Capital Management
SEC 13F filings are viewable for AIHC Capital Management going back to 2026
- AIHC Capital Management 2026 Q1 filed May 8, 2026